AML cells are differentially sensitive to chemotherapy treatment in a human xenograft model. - Wikidata - wikimedia - TriplyDB

AML cells are differentially sensitive to chemotherapy treatment in a human xenograft model.

AML cells are differentially sensitive to chemotherapy treatment in a human xenograft model.

http://www.wikidata.org/entity/Q36709867

about

An advanced preclinical mouse model for acute myeloid leukemia using patients' cells of various genetic subgroups and in vivo bioluminescence imaging An MDS xenograft model utilizing a patient-derived cell line.Cellular intrinsic mechanism affecting the outcome of AML treated with Ara-C in a syngeneic mouse model.Site-Specific Drug-Releasing Polypeptide Nanocarriers Based on Dual-pH Response for Enhanced Therapeutic Efficacy against Drug-Resistant Tumors.Residual Disease in a Novel Xenograft Model of RUNX1-Mutated, Cytogenetically Normal Acute Myeloid Leukemia A ROS-Activatable Agent Elicits Homologous Recombination DNA Repair and Synergizes with Pathway Compounds Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice.Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia.Depletion of the chromatin remodeler CHD4 sensitizes AML blasts to genotoxic agents and reduces tumor formation Therapeutic antagonists of microRNAs deplete leukemia-initiating cell activity.A niche-like culture system allowing the maintenance of primary human acute myeloid leukemia-initiating cells: a new tool to decipher their chemoresistance and self-renewal mechanisms.Functional heterogeneity of genetically defined subclones in acute myeloid leukemia Overexpression of Hiwi Inhibits the Cell Growth of Chronic Myeloid Leukemia K562 Cells and Enhances Their Chemosensitivity to Daunomycin.The role of the proteasome in AML.Patient-derived xenograft (PDX) models in basic and translational breast cancer research.Patient-derived xenotransplants can recapitulate the genetic driver landscape of acute leukemias.Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cells.Transgenic expression of human cytokines in immunodeficient mice does not facilitate myeloid expansion of BCR-ABL1 transduced human cord blood cells.c-myb hyperactivity leads to myeloid and lymphoid malignancies in zebrafish.Phosphodiesterase 5 inhibitor acts as a potent agent sensitizing acute myeloid leukemia cells to 67-kDa laminin receptor-dependent apoptosis.Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism.Gemtuzumab Ozogamicin (GO) Inclusion to Induction Chemotherapy Eliminates Leukemic Initiating Cells and Significantly Improves Survival in Mouse Models of Acute Myeloid Leukemia.R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling.Are we ready to take full advantage of patient-derived tumor xenograft models?Preventing chemotherapy-induced myelosuppression by repurposing the FLT3 inhibitor quizartinib.Inhibition of Endosteal Vascular Niche Remodeling Rescues Hematopoietic Stem Cell Loss in AML.IGH/MYC Translocation Associates with BRCA2 Deficiency and Synthetic Lethality to PARP1 Inhibitors.FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N6-Methyladenosine RNA Demethylase.RNA N6-methyladenosine modification in cancers: current status and perspectives.LKB1, Salt-Inducible Kinases, and MEF2C Are Linked Dependencies in Acute Myeloid Leukemia.Intramuscular Transplantation Improves Engraftment Rates for Esophageal Patient-Derived Tumor Xenografts.Targeting chemotherapy-resistant leukemia by combining DNT cellular therapy with conventional chemotherapy.IMiDs mobilize acute myeloid leukemia blasts to peripheral blood through downregulation of CXCR4 but fail to potentiate AraC/Idarubicin activity in preclinical models of non del5q/5q- AML

P2860

Q27311229-97665A92-D365-408A-AFC7-DA4DBFE25FE9 Q34433095-E8044AD7-CB6D-40E4-952C-00B15520EB2A Q35331086-6CCF013F-D372-45DB-8A0E-36F66C312EDA Q35633363-9C4F78F2-BE60-4C9A-AEB4-7501862D88C3 Q35692708-26D9C365-1AFE-421A-835F-A834613B95C6 Q35792527-26A9E76C-8A80-4C95-B194-8A07C684213D Q35800831-750F1D5A-AEA4-4DFA-A302-871AAAB1C1F0 Q36008395-9B5B650A-0636-4725-8018-FEBC65E2A7C0 Q36070463-352D23C2-721E-49A7-9AC1-F86AB4DFD145 Q37410557-4BBAD430-36B5-4F06-8EB3-2578E22EF417 Q37681007-B888D6C7-3925-4880-8530-8BAC022949BF Q37698123-5D587A86-836C-4C7F-9EDC-42668045585E Q38907442-5D0DFC0F-40E7-4D0E-AF8E-9791D7CB0B19 Q39027087-E6387BD8-D550-4139-A13A-70E4C8EE92A1 Q39057246-F9D5FB78-D529-4CB5-9222-0A0CD68BD8BC Q39642260-924297E6-98BB-4D46-A0ED-3E03B14433FA Q41964099-9A3D13BB-89F5-4C4B-9C86-D4D22AB5A915 Q42375720-1D41C443-94A9-4EC7-B1D7-D7921C839D5B Q43487946-F46FF662-61FA-4BFA-A70B-992FF20E56D4 Q44980700-8F09BFCD-CF05-47B7-B200-D79DF69F1D9A Q46381905-27358638-683E-4DED-82B0-C4D44282F3C7 Q47139006-4A217E3F-5425-4AEB-B0D8-ACC240DB07EC Q47284426-FD9E97DD-E8C3-45CD-8743-CBD44F750720 Q48099042-B7E7F580-BB18-437F-B635-2EB0D66304FF Q48263650-D7BA5CC9-5035-4CE9-B79E-2D506A5AFC23 Q49165603-73D5EF83-9469-4DC8-AC8C-607339519433 Q50933002-954A98C1-B6A5-4662-8813-38BA29DAEC90 Q51236778-6CB0CA08-CB8E-4F00-A55F-766C0FA1F783 Q52311777-6C6EA032-75AD-4797-9AE3-9D4014F8F934 Q52430746-7B950718-C248-4931-BCAB-1A8F8D9A6B13 Q52966216-C7FBCA25-1621-4E18-9736-A068D2F1308D Q55090588-51E54804-DABD-4BA3-B75B-94B1EA1481EC Q57927278-227AF801-9FB8-4C64-B051-C11090722090

P2860

AML cells are differentially sensitive to chemotherapy treatment in a human xenograft model.

http://www.wikidata.org/entity/Q36709867

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

AML cells are differentially s ...... nt in a human xenograft model.

@ast

AML cells are differentially s ...... nt in a human xenograft model.

@en

type

label

AML cells are differentially s ...... nt in a human xenograft model.

@ast

AML cells are differentially s ...... nt in a human xenograft model.

@en

prefLabel

AML cells are differentially s ...... nt in a human xenograft model.

@ast

AML cells are differentially s ...... nt in a human xenograft model.

@en

P1433

Q36709867-8AD44B05-25A2-4F8E-8D4C-85EF968D04F6

P1476

Q36709867-80B3F4D6-E576-4C95-9B7B-08912EDE2768

P2093

Q36709867-4528E7A9-3C2C-4DB5-9497-6C07A074EAE1

Q36709867-5490CCE6-1845-45E8-9544-9211C0E06C6D

Q36709867-6D5F14EE-533A-4C19-A5FE-B3AF7A17347E

Q36709867-A0693F95-CC61-4D19-A8A3-3D31D5F19483

Q36709867-A42100BE-F7A2-4003-937A-2F32A8CC0B53

Q36709867-C2746251-6E12-4911-9156-AD2FED00CD16

P2860

Q36709867-05C22C1C-20AB-473F-9C7B-272292ECBF01

Q36709867-0DCA7B13-38A2-4327-B44E-4ADBA61D455C

Q36709867-19935D59-5A7B-407A-A1CA-E2C5554831BB

Q36709867-1D854EC5-0D75-458D-8C92-C09DB7E2E29D

Q36709867-4015ECA6-8D68-48F5-A515-0E315CB2F27B

Q36709867-4367A8BE-C2BC-40DF-9BA9-1A6F4D7C3C6C

Q36709867-4664C2C8-43D6-440D-B7F0-CA7CBE87226B

Q36709867-4AA6E296-96D4-4843-9C31-02FAA1B70FF1

Q36709867-55224E9F-5D65-46F9-95D5-3F34A77F8FC4

Q36709867-5C4375E8-83F9-4846-B3B5-588BAC9F01DD

P304

Q36709867-F74913D2-1617-4231-A26E-CD3AC61E45AD

P31

Q36709867-39E9D7EC-1005-4C8F-80F5-3C8CE9558C17

P356

Q36709867-1FE4EFE7-1A73-41BE-B78B-8BF6E55CFB08

P407

Q36709867-C7A215BE-841A-40AA-A57A-D30D9C6A1DF6

P433

Q36709867-4E904712-0BFD-403F-B684-BFDCB4846D16

P478

Q36709867-5F5FF7A6-FB17-49A1-806A-9896F21E162F

P50

Q36709867-A7C5A531-ECEA-4B9D-88D7-ADD755980316

P577

Q36709867-3EAF724B-ED35-4176-AACE-F204D16B742B

P5875

Q36709867-A1F330B9-0A81-4C30-9EC1-3F80ABAA6CBB

P698

Q36709867-5E6EC357-895A-4EA3-BE32-9194E705E69B

P921

Q36709867-6692BA22-6A30-4FE8-8C5E-F958A31DDF06

Q36709867-83D5F12D-3B2B-49A1-9065-19D8B23C2011

P932

Q36709867-D82B5CEF-B9AD-43D6-8C5E-5908BB559B0A

P356

BLOOD-2012-10-464677

P1433

P1476

AML cells are differentially s ...... ent in a human xenograft model

@en

P2093

Benjamin Mizukawa

http://www.w3.org/2001/XMLSchema#string

Christina Sexton

http://www.w3.org/2001/XMLSchema#string

James C Mulloy

http://www.w3.org/2001/XMLSchema#string

Mahesh Shrestha

http://www.w3.org/2001/XMLSchema#string

Mark Wunderlich

http://www.w3.org/2001/XMLSchema#string

Yogen Saunthararajah

http://www.w3.org/2001/XMLSchema#string

P2860

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

A severe combined immunodeficiency mutation in the mouse

Transforming human blood stem and progenitor cells: a new way forward in leukemia modeling.

AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3.

Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction.

Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice.

Mouse models of advanced spontaneous metastasis for experimental therapeutics.

Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia.

Mouse models of human AML accurately predict chemotherapy response

P304

e90-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2012-10-464677

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-01-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235371757

http://www.w3.org/2001/XMLSchema#string

P698

23349390

http://www.w3.org/2001/XMLSchema#string

P921

P932

3606073

http://www.w3.org/2001/XMLSchema#string